NCT01657864View on ClinicalTrials.gov

WEUSKOP6166: Lamotrigine and Aseptic Meningitis

CompletedOBSERVATIONAL

Enrollment

1

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Epilepsy

Interventions

DRUG

Lamotrigine

Lamotrigine is an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01657864 - WEUSKOP6166: Lamotrigine and Aseptic Meningitis | Biotech Hunter | Biotech Hunter